Search

Cohava J Gelber

from Nokesville, VA

Cohava Gelber Phones & Addresses

  • 14645 Sulky Run Ct, Nokesville, VA 20181 (703) 596-4629
  • 11 Club Way, Hartsdale, NY 10530 (914) 472-9803
  • Mountain View, CA
  • Chapel Hill, NC
  • Scarsdale, NY
  • Manassas, VA
  • Prince William, VA
  • New York, NY
  • Westfield, NJ

Work

Company: Mannkind corporation 2001 to 2005 Position: Vice president or r and d

Education

Degree: Master of Business Administration, Masters School / High School: Cornell Johnson Graduate School of Management 2000 to 2002

Languages

English

Industries

Biotechnology

Resumes

Resumes

Cohava Gelber Photo 1

Chief Scientific And Technology Officer

View page
Location:
14645 Sulky Run Ct, Nokesville, VA 20181
Industry:
Biotechnology
Work:
Mannkind Corporation 2001 - 2005
Vice President Or R and D

Immunotherap Sep 1997 - Nov 2001
Chief Scientific and Technology Officer

Atcc Sep 1997 - Nov 2001
Chief Scientific and Technology Officer
Education:
Cornell Johnson Graduate School of Management 2000 - 2002
Master of Business Administration, Masters
Weizmann Institute of Science
Doctorates, Doctor of Philosophy, Microbiology
Languages:
English

Business Records

Name / Title
Company / Classification
Phones & Addresses
Cohava Gelber
Chief Executive Officer, Principal
Caerus Discovery, LLC
Commercial Physical Research
Connecticut
14645 Sulky Run Ct, Nokesville, VA 20181

Publications

Us Patents

Myeloma Cell And Ovarian Cancer Cell Surface Glycoproteins, Antibodies Thereto, And Uses Thereof

View page
US Patent:
6986891, Jan 17, 2006
Filed:
Nov 28, 2001
Appl. No.:
09/995522
Inventors:
Cohava Gelber - Hartsdale NY, US
Assignee:
Molecular Discoveries, L.L.C. - New York NY
International Classification:
A61K 39/395
US Classification:
4241551, 4241811, 4241831, 53038885
Abstract:
The present invention is directed to cell surface antigens found on myeloma cells and on ovarian cancer cells, and monoclonal antibodies, and antibody binding fragments thereof, capable of being used for therapeutic, diagnostic, detection and cell purification purposes. An exemplified monoclonal antibody of the present invention recognizes and binds to an epitope common to surface antigen expressed on multiple myeloma cells and on ovarian cancer cells.

Compositions For Treatment Or Prevention Of Bioterrorism

View page
US Patent:
6991779, Jan 31, 2006
Filed:
Jan 17, 2003
Appl. No.:
10/347932
Inventors:
Solomon S. Steiner - Mount Kisco NY, US
Cohava Gelber - Hartsdale NY, US
Robert S. Feldstein - Yonkers NY, US
Assignee:
MannKind Corporation - Valencia CA
International Classification:
A61K 9/12
A61K 9/72
US Classification:
424 45, 424493, 424489, 424490, 12820014
Abstract:
Compositions containing biologically active molecules encapsulated in self-assembling, diketopiperazine microspheres (TECHNOSPHEREs™) and methods for making and administering such compositions are described herein. The compositions can be used to immunize individuals against agents of biological warfare. The biologically active molecules include atropine, antibodies, antigens, and antibiotics. The compositions can be placed in an inhalation device for self-administration. Pulmonary delivery of TECHNOSPHERE™ encapsulated atropine, antibodies, vaccines, and antibiotics provides an accelerated onset of immunity to the targeted disease. Furthermore, the TECHNOSPHERE™ encapsulated atropine, antibodies, vaccines, and antibiotics are stable formulations, suitable for stockpiling, rapid dissemination and mass treatment.

Monoclonal Antibodies And Cell Surface Antigens For The Detection And Treatment Of Small Cell Lung Cancer (Sclc)

View page
US Patent:
7183389, Feb 27, 2007
Filed:
Nov 1, 2001
Appl. No.:
10/015728
Inventors:
Cohava Gelber - Hartsdale NY, US
Assignee:
Molecular Discoveries, LLC - New York NY
International Classification:
C07K 16/00
US Classification:
5303881, 435326
Abstract:
The invention provides new monoclonal antibodies and binding fragments thereof which recognize and immunoreact with cell surface antigens found on small cell lung cancer (SCLC) cells. The antibodies have tumor specificity and are useful for therapy, diagnosis, monitoring, detecting and imaging of SCLC disease and of patients having SCLC disease. The antibody-recognized SCLC-specific surface antigens can serve as targets for detecting, diagnosing, inhibiting or killing SCLC cells.

Ovarian Cancer Cell And Myeloma Cell Surface Glycoproteins, Antibodies Thereto, And Uses Thereof

View page
US Patent:
7226750, Jun 5, 2007
Filed:
Aug 8, 2000
Appl. No.:
10/049608
Inventors:
Cohava Gelber - Hartsdale NY, US
Assignee:
Molecular Discoveries, Inc. - New York NY
International Classification:
G01N 33/574
US Classification:
435 723, 435 71, 435 72, 435330, 530350, 5303871, 5303877, 5303888, 5303897, 5303913, 436 64
Abstract:
The present invention is directed to cell surface antigenes found on myeloma cells and on ovarian cancer cells that are recognized by monoclonal antibodies, and antibody binding fragments thereof, as described. The monoclonal antibodies of the invention are capable of being used for therapeutic, screening, diagnostic and cell purification purposes. A representative and exemplified monoclonal antibody of the present invention recognizes and binds to an epitope common to a surface antigen that is expressed on multiple myeloma cells and to a surface antigen that is expressed on ovarian cancer cells. The function of this monoclonal antibody both in vivo and in vitro is demonstrated.

Monoclonal Antibodies And Cell Surface Antigens For The Detection And Treatment Of Small Cell Lung Cancer (Sclc)

View page
US Patent:
7435415, Oct 14, 2008
Filed:
Sep 29, 2004
Appl. No.:
10/953211
Inventors:
Cohava Gelber - Hartsdale NY, US
Assignee:
ImmunoCellular Therapeutics, Ltd. - Woodlands Hills CA
International Classification:
A61K 39/395
US Classification:
4241421, 4241301, 4241381
Abstract:
The invention provides new monoclonal antibodies and binding fragments thereof which recognize and immunoreact with cell surface antigens found on small cell lung cancer (SCLC) cells. The antibodies have tumor specificity and are useful for therapy, diagnosis, monitoring, detecting and imaging of SCLC disease and of patients having SCLC disease. The antibody-recognized SCLC-specific surface antigens can serve as targets for detecting, diagnosing, inhibiting or killing SCLC cells.

Monoclonal Antibodies And Cell Surface Antigens For The Detection And Treatment Of Small Cell Lung Cancer (Sclc)

View page
US Patent:
7435554, Oct 14, 2008
Filed:
Sep 29, 2004
Appl. No.:
10/954037
Inventors:
Cohava Gelber - Hartsdale NY, US
Assignee:
ImmunoCellular Therapeutics, Ltd. - Woodland Hills CA
International Classification:
G01N 33/577
US Classification:
435 723, 436501, 436518
Abstract:
The invention provides new monoclonal antibodies and binding fragments thereof which recognize and immunoreact with cell surface antigens found on small cell lung cancer (SCLC) cells. The antibodies have tumor specificity and are useful for therapy, diagnosis, monitoring, detecting and imaging of SCLC disease and of patients having SCLC disease. The antibody-recognized SCLC-specific surface antigens can serve as targets for detecting, diagnosing, inhibiting or killing SCLC cells.

Myeloma Cell And Ovarian Cancer Cell Surface Glycoproteins, Antibodies Thereto, And Uses Thereof

View page
US Patent:
7498129, Mar 3, 2009
Filed:
Jan 13, 2006
Appl. No.:
11/332849
Inventors:
Cohava Gelber - Hartsdale NY, US
Assignee:
ImmunoCellular Therapeutics, Ltd. - Woodland Hills CA
International Classification:
C12Q 1/00
G01N 33/53
US Classification:
435 4, 435 71, 435 723
Abstract:
The present invention is directed to cell surface antigens found on myeloma cells and on ovarian cancer cells, and monoclonal antibodies, and antibody binding fragments thereof, capable of being used for therapeutic, diagnostic, detection and cell purification purposes. An exemplified monoclonal antibody of the present invention recognizes and binds to an epitope common to surface antigen expressed on multiple myeloma cells and on ovarian cancer cells.

Monoclonal Antibodies And Cell Surface Antigens For The Detection And Treatment Of Small Cell Lung Cancer (Scls)

View page
US Patent:
7687607, Mar 30, 2010
Filed:
Sep 5, 2008
Appl. No.:
12/205025
Inventors:
Cohava Gelber - Hartsdale NY, US
Assignee:
ImmunoCellular Therapeutics, Ltd. - Woodland Hills CA
International Classification:
C07K 16/30
US Classification:
5303881
Abstract:
The invention provides new monoclonal antibodies and binding fragments thereof which recognize and immunoreact with cell surface antigens found on small cell lung cancer (SCLC) cells. The antibodies have tumor specificity and are useful for therapy, diagnosis, monitoring, detecting and imaging of SCLC disease and of patients having SCLC disease. The antibody-recognized SCLC-specific surface antigens can serve as targets for detecting, diagnosing, inhibiting or killing SCLC cells.
Cohava J Gelber from Nokesville, VA Get Report